BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Gilead Sciences, Inc. 

333 Lakeside Drive

Foster City  California  94404  U.S.A.
Phone: 800-GILEAD-5 or 650-574-3000 Fax: 650-522-5800


SEARCH JOBS




Gilead Sciences is a biopharmaceutical company that discovers, develops, and commercializes innovative therapeutics in areas of unmet medical need.The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, Gilead has operations in North America, Europe and Australia.


 Key Statistics


Email:
Ownership: Public

Web Site: Gilead
Employees: 4,000
Symbol: GILD
 



Industry
Biotechnology






 Company News
As Market Roars, Gilead (GILD) Looking for "Value-Added" Deals, Says CFO 5/22/2015 8:42:17 AM
Gilead (GILD) CFO Says Reliance On Outsourcing Helped It Bump Eli Lilly (LLY) Out of Top 10 Ranking 5/22/2015 6:46:14 AM
I-MAK Release: Patent Challenges In Five Countries Dispute Validity Of Gilead (GILD)'s Claims To Hep C Drug Patents That Block Treatment For Up To 59 Million People 5/20/2015 7:49:16 AM
Achillion (ACHN), Johnson & Johnson (JNJ) Hammer Out $1 Billion+ Hep C R&D Pact to Compete With Gilead (GILD) and AbbVie (ABBV) 5/19/2015 3:42:55 PM
Gilead (GILD) To Present At The UBS 2015 Global Healthcare Conference On Tuesday, May 19 5/19/2015 12:20:29 PM
Twitter Attempts to Marry Gilead (GILD), Achillion (ACHN), Finds Reality Instead 5/19/2015 7:23:20 AM
Here's Why Gilead (GILD) Should Avoid Bigger Deals and Focus on Smaller Cancer-Focused Buyouts 5/15/2015 6:24:22 AM
Gilead (GILD) To Present At The Bank of America (BAC) Merrill Lynch 2015 Health Care Conference On Wednesday, May 13 5/13/2015 11:01:06 AM
Forget Gilead (GILD) - This Tiny Biotech Offers A Much Richer Opportunity 5/12/2015 6:37:57 AM
Gilead (GILD)'s CEO: One Breakthrough Drug After Another 5/7/2015 6:48:37 AM
12345678910...